This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

InVision Valuation

Is IVX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IVX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate IVX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate IVX's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IVX?

Key metric: As IVX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for IVX. This is calculated by dividing IVX's market cap by their current revenue.
What is IVX's PS Ratio?
PS Ratio	0.9x
Sales	€15.46m
Market Cap	€13.19m

IVX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1x
Enterprise Value/EBITDA	-9.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does IVX's PS Ratio compare to its peers?

The above table shows the PS ratio for IVX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.6x
DTD2 B+S Banksysteme	1x	4.5%	€12.9m
TR9 OTRS	2.7x	6.9%	€32.0m
TBX0 tick Trading Software	2.2x	3.0%	€17.1m
LSX LS telcom	0.5x	5.0%	€20.3m
IVX InVision	0.9x	n/a	€13.2m

Price-To-Sales vs Peers: IVX is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (2.1x).

Price to Sales Ratio vs Industry

How does IVX's PS Ratio compare vs other companies in the DE Software Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
CSH CENIT	0.4x	5.2%	US$74.07m
CLIQ Cliq Digital	0.09x	13.2%	US$25.62m
LSX LS telcom	0.5x	5.0%	US$21.11m

7 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: IVX is good value based on its Price-To-Sales Ratio (0.9x) compared to the German Software industry average (1.8x).

Price to Sales Ratio vs Fair Ratio

What is IVX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IVX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.9x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate IVX's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

DATAGROUP

€369.5m

Provides information technology (IT) solutions in Germany and internationally.

D6H

€44.35

14.9%

-17.6%

Kontron

€1.0b

Engages in the provision of internet of things (IoT) solutions in Austria and internationally.

SANT

€16.94

-3.2%

-24.8%

TeamViewer

€1.8b

Develops and distributes remote connectivity solutions worldwide.

TMV

€11.60

-3.4%

-13.4%